cyclopentane has been researched along with Rhabdoid Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayyildiz, D; Calandrini, C; de Heus, C; de Krijger, RR; Derakhshan, S; Dolman, MEM; Drost, J; Kool, M; Langenberg, KPS; Liv, N; Molenaar, JJ; Paassen, I; Tytgat, GAM; van de Ven, M; van den Heuvel-Eibrink, MM; van Hooff, SR | 1 |
1 other study(ies) available for cyclopentane and Rhabdoid Tumor
| Article | Year |
|---|---|
Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors.
Topics: Animals; Cell Line, Tumor; Cyclopentanes; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred NOD; Mice, SCID; Organoids; Pyrimidines; Rhabdoid Tumor; Unfolded Protein Response; Xenograft Model Antitumor Assays | 2021 |